{"id":"W1988557714","doi":"10.1016/j.ctrv.2003.10.002","title":"Epidermal growth factor receptor: a promising target in solid tumours","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Epidermal growth factor receptor; Monoclonal antibody; Tyrosine kinase; Cancer research; Cancer; Receptor tyrosine kinase; Signal transduction; Targeted therapy; EGFR inhibitors; Cetuximab; Blockade; Pharmacology; Receptor; Immunology; Antibody; Internal medicine; Biology; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.000790698,0.001349577,0.007459244,0.0005395356,0.00009866651,0.00006892691,0.0003694707,0.000513508,0.003916231],"category_scores_gemma":[0.0002753176,0.0008836304,0.001610792,0.001137388,0.0001342632,0.0001192501,0.00007191265,0.0009851505,0.001062525],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009079195,"about_ca_system_score_gemma":0.004091311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004139974,"about_ca_topic_score_gemma":0.00008933489,"domain_scores_codex":[0.9932879,0.001267238,0.002140364,0.001423238,0.0005969771,0.001284344],"domain_scores_gemma":[0.9971007,0.0001809183,0.0007959245,0.001167856,0.0001266059,0.0006280295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002014348,0.000332472,0.0008249507,0.04519694,0.0002756271,0.0001690385,0.0001260003,1.348701e-7,0.000002645503,0.000009127849,0.01052856,0.9425144],"study_design_scores_gemma":[0.001075646,0.0003924149,0.00001747315,0.08023968,0.001015755,0.00009540491,0.000006099575,8.409235e-7,0.00003937689,0.000007022225,0.9165167,0.000593631],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001035357,0.9832271,0.000005201561,0.0002506722,0.0006892885,0.0109526,0.0002553012,0.00006665038,0.004542847],"genre_scores_gemma":[0.000001971731,0.982815,0.001100052,0.0002211349,0.0007580787,0.009762565,0.0003563224,0.0002449556,0.004739876],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9419207,"threshold_uncertainty_score":0.9999255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2218575342477881,"score_gpt":0.4851877966864617,"score_spread":0.2633302624386736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}